17 research outputs found
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
Get PDFBACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362
Shape-induced capillary interactions of colloidal particles
Get PDFWe show that near-spherical micrometer-sized colloidal particles at an interface of two fluids experience inter-particle forces merely as a consequence of their shape-induced capillary interaction. The interaction is strong even if the deviations from sphericity are on the nm-scale, and can hardly be avoided in experiment. For particles of 2 μm radius, a deformation of 20 nm can result in an attractive potential of 2kBT at a distance of 4 particle radii. Dynamical simulations of many particles confirm that the forces lead to aggregates of dendritic or hexagonal-lattice type. The latter pattern exhibits strong herringbone-phase orientational order
Shape-induced capilary interactions of colloidal particles
No full textWe show that near-spherical micrometer-sized colloidal particles at an interface of two fluids experience inter-particle forces merely as a consequence of their shape-induced capillary interaction. The interaction is strong even if the deviations from sphericity are on the nm-scale, and can hardly be avoided in experiment. For particles of 2 μm radius, a deformation of 20 nm can result in an attractive potential of 2kBT at a distance of 4 particle radii. Dynamical simulations of many particles confirm that the forces lead to aggregates of dendritic or hexagonal-lattice type. The latter pattern exhibits strong herringbone-phase orientational order
The Frankel Law for the Thickness of Vertically Withdrawn Soap Films: Reconsidering the Basic Fluid Dynamical
No full textinfo:eu-repo/semantics/publishe
Method for producing films
No full textThe present invention provides a process for producing thin solid films of a substance by drawing a thin liquid film of the substance from a bath, stabilizing the film in a liquid state by inducing a surface tension gradient along the length of the film, and subsequent cooling or curing to form a solid film. The present process permits contact- free thin films to be produced more rapidly than conventional processes, and allows precise control of the final film thickness.info:eu-repo/semantics/publishe
Thermocapillary-assisted pulling of contact-free liquid films
No full textinfo:eu-repo/semantics/publishe
External ear anomalies and hearing impairment in Noonan Syndrome
No full textItem does not contain fulltextOBJECTIVE: This is the first cohort in which hearing impairment and external ear anomalies in Noonan Syndrome are described extensively. METHODS: Retrospective analysis of the otorhinolaryngological and clinical genetic data from 97 Noonan Syndrome (NS) patients. Forty-four NS patients were seen by an otorhinolaryngologist for the analysis of hearing impairment. In our cohort 80 of the 97 patients were genetically tested. In 71 of these mutations were found: in 48 patients a mutation in PTPN11, in 10 patients in SOS1, in 5 patients in SHOC2, in 5 patients in RAF1, in 1 patient in MAP2K2, in 1 patient in KRAS and in 1 patient in A2ML1. RESULTS: External ear anomalies were reported in 75 NS patients (77%). In 69 patients the ears were low-set, 28 patients had posteriorly rotated ears, 14 patients showed protruding ears and 18 had thickened helices. Hearing impairment was detected in 34 NS patients. Nine patients had sensorineural hearing impairment, two a permanent conductive hearing impairment, two other patients had mixed hearing impairment and 20 patients had conductive hearing impairment in the past, caused by otitis media with effusion. Their temporary conductive hearing impairment resolved between the ages of 2 and 18 years. Sensorineural hearing impairment varied between mild high-frequency hearing impairment and profound (uni- and bilateral) hearing impairment and was progressive in three patients. Four NS patients received cochlear implants for their severe sensorineural hearing impairment. The cohort is small for genotype-phenotype correlations, but sensorineural hearing impairment, especially the bilateral severe hearing impairment, was only seen in patients with a PTPN11 mutation. CONCLUSION: NS is characterized by dysmorphic external ear anomalies and both sensorineural and conductive hearing impairment. Audiological examinations are recommended in all patients with Noonan Syndrome
